MD654Y - Metoda de pronosticare a evolutiei melanomului malign de stadiul II si III - Google Patents

Metoda de pronosticare a evolutiei melanomului malign de stadiul II si III Download PDF

Info

Publication number
MD654Y
MD654Y MDS20120167A MD654Y MD 654 Y MD654 Y MD 654Y MD S20120167 A MDS20120167 A MD S20120167A MD 654 Y MD654 Y MD 654Y
Authority
MD
Moldova
Prior art keywords
course
malignant melanoma
predicting
iii stage
tct
Prior art date
Application number
Other languages
English (en)
Moldavian (mo)
Inventor
Valeriu Palade
Constantin Jucovschi
Victor Cernat
Gheorghe Tabarna
Iulian Turcanu
Original Assignee
Valeriu Palade
Constantin Jucovschi
Victor Cernat
Gheorghe Tabarna
Iulian Turcanu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valeriu Palade, Constantin Jucovschi, Victor Cernat, Gheorghe Tabarna, Iulian Turcanu filed Critical Valeriu Palade
Priority to MDS20120167A priority Critical patent/MD654Z/ro
Publication of MD654Y publication Critical patent/MD654Y/ro
Publication of MD654Z publication Critical patent/MD654Z/ro

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Inventia se refera la medicina, în special la oncologie si poate fi utilizata pentru pronosticarea evolutiei melanomului malign de stadiul II si III.Conform inventiei, metoda revendicata include examenul clinic si paraclinic, unde se stabilesc urmatorii parametri: concretizarea stadiului bolii (ST), prezenta ulceratiei (U), tipul celular al tumorii (TCT), nivelul de invazie dupa Clark (NI), grosimea tumorii dupa Breslow (GT); metoda de tratament aplicata (MT) si sexul pacientului (SP), apoi se calculeaza functia discriminanta (F) conform formulei:F= -6,345 + 1,386 × ST + 4,768 × MT - 2,596 × SP - 3, 384 × U + 0,806 × TCT + 1,780 × NI - 1, 136 × GT.În cazul în care F < 0 se prognozeaza o evolutie favorabila a melanomului malign, iar când F > 0 - o evolutie nefavorabila.
MDS20120167A 2012-11-20 2012-11-20 Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III MD654Z (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20120167A MD654Z (ro) 2012-11-20 2012-11-20 Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20120167A MD654Z (ro) 2012-11-20 2012-11-20 Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III

Publications (2)

Publication Number Publication Date
MD654Y true MD654Y (ro) 2013-07-31
MD654Z MD654Z (ro) 2014-02-28

Family

ID=48875337

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20120167A MD654Z (ro) 2012-11-20 2012-11-20 Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III

Country Status (1)

Country Link
MD (1) MD654Z (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD726Z (ro) * 2013-07-23 2014-08-31 Адриан КИШКА Metodă de pronostic al evoluţiei stărilor precanceroase gastrice la bărbaţi

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD239Z (ro) * 2010-02-15 2011-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de pronosticare a evoluţiei clinice a cancerului glandei mamare stadiul I
  • 2012

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD726Z (ro) * 2013-07-23 2014-08-31 Адриан КИШКА Metodă de pronostic al evoluţiei stărilor precanceroase gastrice la bărbaţi

Also Published As

Publication number Publication date
MD654Z (ro) 2014-02-28

Similar Documents

Publication Publication Date Title
WO2014205555A8 (en) Methods and uses for diagnosis and treatment of prostate cancer
EA201201373A1 (ru) Антитело, распознающее лейкемический ингибиторный фактор (lif) человека, и применение антител против lif при лечении заболеваний, связанных с нежелательной пролиферацией клеток
WO2010091049A3 (en) Diagnosis and treatment of cancer
MX2010004074A (es) Combinacion 059.
EP4303584A3 (en) Methods for detecting signatures of disease or conditions in bodily fluids
EA201201030A1 (ru) 5-алкинилпиримидины
WO2009039397A3 (en) Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer
MX2011006555A (es) Compuestos de tiazolopiridina moduladores de sirtuina.
MX2012010418A (es) Inhibidores syk de imidazopiridinas.
WO2009009752A3 (en) Genetic models for stratification of cancer risk
PH12012500620A1 (en) Compounds
EA200901555A1 (ru) Композиция местного применения по уходу за кожей и способ лечения
TN2011000627A1 (en) Disubstituted phthalazine hedgehog pathway antagonists
EP4356960A3 (en) Biomarkers and methods of treating pd-1 and pd-l1 related conditions
UA111756C2 (uk) Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
TN2011000259A1 (en) Substituted pyrimidines for the treatment of diseases such as cancer
MX2010005186A (es) Tiazolopiridinas solubilizadas.
MX365365B (es) Induccion de gen de trail de molécula pequeña en células normales y tumorales como una terapia anticáncer.
MY201732A (en) Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof
WO2011126833A3 (en) Anti-inflammatory factors
WO2010059241A3 (en) Treatment of amyotrophic lateral sclerosis
EP4327886A3 (en) Pyrimido- pyridazinone compounds and use thereof
MX2010009488A (es) Métodos para modular la actividad del receptor de mc5, y tratamiento de las afecciones relacionadas con este receptor.
WO2013106766A3 (en) THERAPEUTIC INDICATIONS OF miR-1291
EP4327818A3 (en) Improved anti-senescence compounds and uses for the treatment of cancer

Legal Events

Date Code Title Description
FG9Y Short term patent issued
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)
MM4Y Short-term patent definitely lapsed due to non-payment of fees